![]() ![]() He is the author of 34 medical papers and abstracts and has more than 500 issued and pending patents.Īmanda has nearly 20 years of up-and-downstream product management and marketing leadership experience in the medical device space. Belson also spent one year as a research fellow with the Biomedical Technology Innovation Program at Stanford. He did his pediatric residency at Dana Children’s Hospital in Tel Aviv and his pediatric nephrology fellowship at Lucile Packard Children’s Hospital at Stanford University. ![]() Belson also serves as a board director of Relimetrics and QT Vascular.īelson graduated cum laude from the school of medicine of the Technion, Israel Institute of Technology, in Haifa, Israel. Modular Surgical develops new minimally invasive surgery technology, and PAFA develops atrial fibrillation ablation technology.ĭr. Emboline, which develops proprietary embolic protection technology. Radiaction Medical is a radiation protection medical device company. Qool Therapeutics is a minimally invasive therapeutic hypothermia technology company. Zipline Medical, a wound closure technology company, was acquired by Stryker. Vascular Pathways, a vascular intervention technology acquired by C R Bard. It was a significant milestone for us to show B-Laser’s ability to cross a highly calcified lesion using the step-by-step technique without the need to cross with a wire first in very challenging scenarios (including long and severely calcific lesions),” said Yoel Zabar, CEO of Eximo Medical.Amir Belson, M.D., was the founder of Neoguide Systems, which Intuitive Surgical acquired in 2009. We continue to leverage the inherent advantages of our unique short pulse 355nm laser platform to develop novel techniques and expand our system’s utilization and market opportunity. “Eximo is extremely excited with the current commercial progress the B-Laser is experiencing in the competitive U.S. The B-Laser has so far been used to treat patients who have highly complex, highly calcified lesions above and below the arterial segments in the knee. I am very proud to be part of this exciting technology and journey.” “The capability to cross chronically occluded arteries without needing to cross with a wire first, and to then be able to perform atherectomy over a wire by using the same catheter represents a welcomed and significant addition to our toolkit as it addresses a real unmet need in our practice. ![]() Luis Leon, a clinician that has begun using the B-Laser system to treat patients, in a press release. I am very excited to work with Eximo using the B-Laser in a variety of PAD patients and to incorporate it routinely in our outpatient-based laboratory,” said Dr. “There is a well-known paucity of devices that allows interventionists to cross occlusive lesions in an intraluminal path as opposed to sub-intimal. Eximo’s On-Line Photo-Acoustic Signal Monitoring was also implemented for the first time during the study and showed that machine learning can help interventionists characterize materials that are in contact with catheter tips while also providing a warning signal to prevent vessel injury and procedural complications. The step-by-step crossing approach uses a standard B-Laser catheter followed by the atherectomy using the same catheter that is used with standard guidewires.ĭuring a Polish study, the B-Laser system was successful without complications, including in long and severely calcified lesions. The system was launched in a step-by-step approach for therapy in patients who have highly complex, arterial occlusive peripheral arterial disease. Eximo Medical has recently launched its B-Laser Atherectomy System for patients who have arterial occlusive peripheral arterial disease. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |